NCT00006235View on ClinicalTrials.gov

Liposomal Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Primary Completion Date

February 28, 2006

Conditions
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Interventions
DRUG

carboplatin

DRUG

pegylated liposomal doxorubicin hydrochloride

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Gynecologic Oncology Group

NETWORK